Drug regulatory and postal departments of China jointly guard against selling counterfeit drugs through postal and express delivery
The State Post Bureau and the State Food and Drug Administration (SFDA) of China recently jointly issued a notice, which requires postal regulatory departments and drug regulatory departments at all levels to strengthen cooperation to severely crackdown on selling counterfeit drugs through postal and express delivery.
